Compared with 177Lu-PSMA-I&T, 177Lu-rhPSMA-10.1 significantly reduced tumor growth from day 39 (P < 0.05) to day 49 (P < 0.01), whereas 177Lu-PSMA-617 significantly reduced tumor growth on day 49 only (P < 0.05). The gene discussed is FOLH1; the disease is neoplasm.